BioActor is a biotechnology company that develops and markets health ingredients for dietary supplements and functional foods.

The company focuses on the development of proprietary bioactives with human clinical evidence that address health concerns related to metabolic syndrome and ageing.

We operate on a business to business level and aim at concluding long term partnerships with leading marketing companies of dietary supplements and functional foods.

BioActor’s products are all natural, innovative and scientifically validated for their health benefits.

The Company’s product pipeline consists of five lead products:

	BONOLIVE® for the prevention of bone-loss
	HESPERION™ a full spectrum heart health ingredient to foster a healthy bloodflow
	NAXUS® for systemic glyceamic control and prebiotic fibre effects
	TENSIOCONTROL® peptides derived from egg-white for the prevention of hypertension
	SATURN® pea protein for weight management.

BioActor was founded in 2005 by an experienced biotech entrepreneur and a pharmacologist to further develop and commercialize recent scientific discoveries of its research partners CSIC, INRA and Ghent University. Through its network of scientific collaborations, the company has access to a number of highly regarded scientific advisors.